Clinical Trial Update: Caduet in an Untreated Subject Population [Phase 4]

View source ↗

Summary

Phase 4 trial update for Caduet in untreated subjects showing completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Drugs mentioned

• Caduet (amlodipine/atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypertension, Dyslipidemia | Phase 4 | Status: COMPLETED